PE104798A1 - Compuestos utiles para la inhibicion de la enzima farnesilo transferasa - Google Patents
Compuestos utiles para la inhibicion de la enzima farnesilo transferasaInfo
- Publication number
- PE104798A1 PE104798A1 PE1998000505A PE00050598A PE104798A1 PE 104798 A1 PE104798 A1 PE 104798A1 PE 1998000505 A PE1998000505 A PE 1998000505A PE 00050598 A PE00050598 A PE 00050598A PE 104798 A1 PE104798 A1 PE 104798A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- aryl
- formula
- tumor cells
- farnesilo
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000004357 Transferases Human genes 0.000 title 1
- 108090000992 Transferases Proteins 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 210000004881 tumor cell Anatomy 0.000 abstract 3
- 101100240521 Caenorhabditis elegans nhr-16 gene Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 201000002528 pancreatic cancer Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87774197A | 1997-06-17 | 1997-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE104798A1 true PE104798A1 (es) | 1999-11-06 |
Family
ID=25370618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000505A PE104798A1 (es) | 1997-06-17 | 1998-06-15 | Compuestos utiles para la inhibicion de la enzima farnesilo transferasa |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0989983B1 (https=) |
| JP (1) | JP2002504144A (https=) |
| KR (1) | KR100640672B1 (https=) |
| CN (1) | CN1266433A (https=) |
| AR (1) | AR012991A1 (https=) |
| AT (1) | ATE273299T1 (https=) |
| AU (1) | AU753658B2 (https=) |
| CA (1) | CA2293714C (https=) |
| DE (1) | DE69825589T2 (https=) |
| ES (1) | ES2224408T3 (https=) |
| HU (1) | HUP0003138A3 (https=) |
| IL (2) | IL133386A0 (https=) |
| MY (1) | MY143570A (https=) |
| NZ (1) | NZ501376A (https=) |
| PE (1) | PE104798A1 (https=) |
| TW (1) | TW587935B (https=) |
| WO (1) | WO1998057960A1 (https=) |
| ZA (1) | ZA985203B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6362188B1 (en) | 1998-12-18 | 2002-03-26 | Schering Corporation | Farnesyl protein transferase inhibitors |
| HUP0202152A2 (en) * | 1998-12-18 | 2002-10-28 | Schering Corp | Tricyclyc farnesyl protein transferase inhibitors |
| US6800636B2 (en) | 1998-12-18 | 2004-10-05 | Schering Corporation | Farnesyl protein transferase inhibitors |
| TR200101754T2 (tr) * | 1998-12-18 | 2002-05-21 | Schering Corporation | Farnezil protein transferaz inhibitörleri |
| US6372747B1 (en) | 1998-12-18 | 2002-04-16 | Schering Corporation | Farnesyl protein transferase inhibitors |
| US6432959B1 (en) * | 1998-12-23 | 2002-08-13 | Schering Corporation | Inhibitors of farnesyl-protein transferase |
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| WO2002056884A2 (en) * | 2001-01-22 | 2002-07-25 | Schering Corporation | Treatment of malaria with farnesyl protein transferase inhibitors |
| WO2002080895A2 (en) * | 2001-04-06 | 2002-10-17 | Schering Corporation | Treatment of malaria with farsenyl protein transferase inhibitors |
| EP1542993B1 (en) | 2002-09-20 | 2012-12-19 | Merck Serono SA | Piperazine derivatives and methods of use |
| EP1838324A2 (en) | 2004-12-13 | 2007-10-03 | Schering Corporation | Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| EP1833481A1 (en) | 2004-12-14 | 2007-09-19 | Schering Corporation | Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| ES2798289T3 (es) * | 2012-01-25 | 2020-12-10 | Novartis Ag | Compuestos heterocíclicos y métodos para su uso |
| EP3541375B1 (en) * | 2016-11-18 | 2023-08-23 | Merck Sharp & Dohme LLC | Factor xiia inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| CA2174105C (en) * | 1993-10-15 | 2002-02-12 | W. Robert Bishop | Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| IL117797A0 (en) * | 1995-04-07 | 1996-08-04 | Pharmacopeia Inc | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| US5712280A (en) * | 1995-04-07 | 1998-01-27 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
-
1998
- 1998-06-15 CN CN98808124A patent/CN1266433A/zh active Pending
- 1998-06-15 NZ NZ501376A patent/NZ501376A/en not_active IP Right Cessation
- 1998-06-15 AT AT98928886T patent/ATE273299T1/de not_active IP Right Cessation
- 1998-06-15 PE PE1998000505A patent/PE104798A1/es not_active Application Discontinuation
- 1998-06-15 JP JP50449099A patent/JP2002504144A/ja not_active Ceased
- 1998-06-15 KR KR1019997011842A patent/KR100640672B1/ko not_active Expired - Fee Related
- 1998-06-15 ZA ZA985203A patent/ZA985203B/xx unknown
- 1998-06-15 DE DE69825589T patent/DE69825589T2/de not_active Expired - Lifetime
- 1998-06-15 HU HU0003138A patent/HUP0003138A3/hu unknown
- 1998-06-15 ES ES98928886T patent/ES2224408T3/es not_active Expired - Lifetime
- 1998-06-15 IL IL13338698A patent/IL133386A0/xx active IP Right Grant
- 1998-06-15 TW TW087109501A patent/TW587935B/zh not_active IP Right Cessation
- 1998-06-15 EP EP98928886A patent/EP0989983B1/en not_active Expired - Lifetime
- 1998-06-15 CA CA002293714A patent/CA2293714C/en not_active Expired - Fee Related
- 1998-06-15 WO PCT/US1998/011495 patent/WO1998057960A1/en not_active Ceased
- 1998-06-15 AU AU80580/98A patent/AU753658B2/en not_active Ceased
- 1998-06-16 AR ARP980102862A patent/AR012991A1/es unknown
- 1998-06-16 MY MYPI98002697A patent/MY143570A/en unknown
-
1999
- 1999-12-08 IL IL133386A patent/IL133386A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2224408T3 (es) | 2005-03-01 |
| CA2293714C (en) | 2009-09-08 |
| HUP0003138A3 (en) | 2002-11-28 |
| AR012991A1 (es) | 2000-11-22 |
| MY143570A (en) | 2011-05-31 |
| HUP0003138A2 (hu) | 2001-06-28 |
| KR100640672B1 (ko) | 2006-11-02 |
| DE69825589T2 (de) | 2005-09-08 |
| EP0989983A1 (en) | 2000-04-05 |
| EP0989983B1 (en) | 2004-08-11 |
| NZ501376A (en) | 2002-03-28 |
| CA2293714A1 (en) | 1998-12-23 |
| ATE273299T1 (de) | 2004-08-15 |
| DE69825589D1 (de) | 2004-09-16 |
| JP2002504144A (ja) | 2002-02-05 |
| CN1266433A (zh) | 2000-09-13 |
| KR20010013822A (ko) | 2001-02-26 |
| TW587935B (en) | 2004-05-21 |
| ZA985203B (en) | 1999-01-05 |
| AU8058098A (en) | 1999-01-04 |
| IL133386A0 (en) | 2001-04-30 |
| AU753658B2 (en) | 2002-10-24 |
| WO1998057960A1 (en) | 1998-12-23 |
| IL133386A (en) | 2006-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE104798A1 (es) | Compuestos utiles para la inhibicion de la enzima farnesilo transferasa | |
| DK0931788T3 (da) | Metalloproteasehæmmere | |
| PT96897A (pt) | Processo para a preparacao de novos compostos aril-e heteroariletilenicos e de composicoes farmaceuticas que os contem | |
| ATE6422T1 (de) | 3-aryloxy-3-phenylpropylamine. | |
| CY1106223T1 (el) | Μεθοδοι διαμορφωσης λειτουργιας σepινης/θρεονινης πρωτεϊνης κινασης με βασισμενες σε 5-αζακινοξαλινη ενωσεις | |
| DK0792641T3 (da) | Anvendelse af estrogenantagonister og estrogenagonister til hæmning af patologiske tilstande | |
| DK0641355T3 (da) | Anvendelse af sulfamatderivater som steroid-sulfatase-inhibitorer | |
| NO972909L (no) | Substituerte azetidin-2-oner for behandling av atherosklerose | |
| ES2194346T3 (es) | Compuestos que contienen boro y aluminio. | |
| ES2180271T3 (es) | Colorantes de trifendioxazina para el teñido de substratos organicos. | |
| AR241531A1 (es) | Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables. | |
| AU7748687A (en) | Phenolic corrosion inhibitors for coating materials | |
| SE7906638L (sv) | Peptidderivat | |
| DK162044C (da) | Fungicidt indanylbenzamidderivat, fremgangsmaade til fremstilling heraf samt fungicidt middel indeholdende det | |
| AU2355384A (en) | Pyridyl-thiadiazole derivatives | |
| CO4940417A1 (es) | DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
| BR9813923A (pt) | N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos | |
| DE69808922D1 (de) | Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen | |
| NO994995D0 (no) | Fremgangsmåte for identifisering av forbindelser for inhibering av neoplastiske lesjoner og farmasöytiske blandinger inneholdende slike forbindelser | |
| ES447751A1 (es) | Procedimiento para preparar derivados de imidazolilquinazo- lina. | |
| DK0667863T3 (da) | 2-Perhalogenalkyl-substituerede benzimidazoler, deres fremstilling samt deres anvendelse som pesticider | |
| DK0984919T3 (da) | Fremgangsmåde til fremstilling af arylmalonater | |
| DK293890A (da) | 3-oe2,(4-arylpiperazin1-yl)-ethoxylaap-cymen, derivater deraf, som er ortho-, meta- og paramonosubstituerede eller -disubstituerede paa phenylringen, fremgangsmaade til fremstilling af saadanne derivater samt laegemidler, hvori forbindelserne er til stede som det aktive middel | |
| PE20040711A1 (es) | Compuestos de haloalqueno, proceso para su produccion y pesticidas que los contienen | |
| ID27500A (id) | Senyawa-senyawa organik |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |